appreciate your quick read on imcl(owned twice-currently 700 shares; the message board,management, buyout all seem totally disfunctional)-thanks-as you can guess i have little micro-knowledge on medecine but do follow all that is posted. thanks
I think that once IMCL files for the H&N indication and the FDA accepts that indication, that the resulting sales and 250 million BMS dollars will move IMCL up again. IMCL is a pretty good value at this price. I agree with those on the board that say BMS has not been a good partner.